Taiyen Biotech Co Ltd (1737) — Capital Reinvestment Ratio
Latest as of March 2026:
0.26x
Taiyen Biotech Co Ltd (1737) has a Capital Reinvestment Ratio of 0.26x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$173.44 Million) in capital expenditures (NT$44.39 Million). See 1737 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
NT$173.44 Million
TWD
Capital Expenditures
NT$44.39 Million
TWD
Data as of
Mar 2026
Most recent filing
Taiyen Biotech Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Taiyen Biotech Co Ltd's Capital Reinvestment Ratio across 23 annual periods.
Annual Capital Reinvestment Ratio for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Taiyen Biotech Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see Taiyen Biotech Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | NT$473.77 Million | NT$300.16 Million | ▲ +36.0% |
| 2024 | 0.47x | NT$660.12 Million | NT$307.61 Million | ▼ -38.6% |
| 2023 | 0.76x | NT$454.54 Million | NT$345.13 Million | ▲ +78.8% |
| 2022 | 0.42x | NT$580.69 Million | NT$246.60 Million | ▼ -34.8% |
| 2021 | 0.65x | NT$600.08 Million | NT$390.81 Million | ▼ -17.5% |
| 2020 | 0.79x | NT$339.36 Million | NT$267.89 Million | ▼ -8.1% |
| 2019 | 0.86x | NT$330.81 Million | NT$284.25 Million | ▲ +29.5% |
| 2018 | 0.66x | NT$449.83 Million | NT$298.49 Million | ▲ +9.1% |
| 2017 | 0.61x | NT$607.87 Million | NT$369.68 Million | ▲ +81.5% |
| 2016 | 0.33x | NT$568.06 Million | NT$190.30 Million | ▲ +20.7% |
| 2015 | 0.28x | NT$383.93 Million | NT$106.57 Million | ▼ -30.8% |
| 2014 | 0.40x | NT$371.06 Million | NT$148.81 Million | ▼ -12.9% |
| 2013 | 0.46x | NT$203.21 Million | NT$93.53 Million | ▼ -35.0% |
| 2012 | 0.71x | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$3.42 Billion | NT$94.39 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow